117 related articles for article (PubMed ID: 10748695)
1. [Importance of drug surveillance in psychiatry--the AMSP project].
Zullino D; Baumann P; Grohmann R; Greil W
Rev Med Suisse Romande; 2000 Feb; 120(2):105-9. PubMed ID: 10748695
[No Abstract] [Full Text] [Related]
2. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
[TBL] [Abstract][Full Text] [Related]
3. The AMSP drug safety program: methods and global results.
Grohmann R; Engel RR; Rüther E; Hippius H
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S4-11. PubMed ID: 15052509
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions and reporting.
Witte R
Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
[No Abstract] [Full Text] [Related]
5. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
[TBL] [Abstract][Full Text] [Related]
6. Patterns of drug use in psychiatric inpatient wards.
Swett C
J Clin Psychiatry; 1979 Nov; 40(11):464-8. PubMed ID: 489528
[TBL] [Abstract][Full Text] [Related]
7. Cardiac adverse effects associated with psychotropic drugs.
Schmid C; Grohmann R; Engel RR; Rüther E; Kropp S
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S65-9. PubMed ID: 15052516
[TBL] [Abstract][Full Text] [Related]
8. Galactorrhea due to psychotropic drugs.
Kropp S; Ziegenbein M; Grohmann R; Engel RR; Degner D
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S84-8. PubMed ID: 15052519
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacovigilance as new direction of research].
Gaszner G; Makkos Z; Gaszner P
Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
[TBL] [Abstract][Full Text] [Related]
10. Recognizing, reporting, and reducing adverse drug reactions.
Brown SD; Landry FJ
South Med J; 2001 Apr; 94(4):370-3. PubMed ID: 11332899
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study.
Grohmann R; Engel RR; Geissler KH; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S27-38. PubMed ID: 15052512
[TBL] [Abstract][Full Text] [Related]
12. Reporting adverse reactions to medicines.
Ferguson R
Nurs N Z; 1999 Dec-2000 Jan; 5(11):11. PubMed ID: 12008207
[No Abstract] [Full Text] [Related]
13. Blood dyscrasias induced by psychotropic drugs.
Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig WD; Wagner G; Müller-Oerlinghausen B; Möller HJ; Hippius H; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S70-8. PubMed ID: 15052517
[TBL] [Abstract][Full Text] [Related]
14. Adverse events temporally associated with immunizing agents.
Duclos P; Pless R; Koch J; Hardy M
Can Fam Physician; 1993 Sep; 39():1907-13. PubMed ID: 8219839
[TBL] [Abstract][Full Text] [Related]
15. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
[TBL] [Abstract][Full Text] [Related]
16. [Approaches to classifying adverse reactions of radiopaque substances].
Napolov IuK; Korobkova IZ; Chekavskaia OV; Gorgadze TT; Kalinichev SA
Vestn Rentgenol Radiol; 2006; (4):53-62. PubMed ID: 17633888
[No Abstract] [Full Text] [Related]
17. Research methods in drug surveillance.
Engel RR; Grohmann R; Rüther E; Hippius H
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S12-5. PubMed ID: 15052510
[TBL] [Abstract][Full Text] [Related]
18. [Depression wards--1998 structure and process quality].
Wolfersdorf M; Lehle B
Psychiatr Prax; 2003 May; 30 Suppl 2():S140-2. PubMed ID: 14509061
[TBL] [Abstract][Full Text] [Related]
19. Design and methods of the 'monitoring outcomes of psychiatric pharmacotherapy' (MOPHAR) monitoring program - a study protocol.
Simoons M; Ruhé HG; van Roon EN; Schoevers RA; Bruggeman R; Cath DC; Muis D; Arends J; Doornbos B; Mulder H
BMC Health Serv Res; 2019 Feb; 19(1):125. PubMed ID: 30764821
[TBL] [Abstract][Full Text] [Related]
20. Improving self-reporting of adverse drug events in a West Virginia hospital.
Schade CP; Hannah K; Ruddick P; Starling C; Brehm J
Am J Med Qual; 2006; 21(5):335-41. PubMed ID: 16973950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
